Stay updated with breaking news from Specific Quality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Almost a third of patients with migraine have experienced some form of stigma in new findings that researchers say should prompt efforts to address this common and "stubborn" social problem.
The randomized, placebo-controlled segment of the study showed that AD109 had a statistically significant and clinically meaningful difference from placebo after a single dose in the patients’ hypoxic burden.